[Cancer incidence and mortality across diverse geographical regions in China, 2024] - PubMed
3 hours ago
- #disease burden
- #China health statistics
- #cancer epidemiology
- Estimated 5,150,600 new cancer cases in China in 2024 (2,672,000 males, 2,478,600 females).
- Age-standardized incidence rate (ASIRW) of 207.70 per 100,000 (higher in urban areas at 215.71 vs. rural at 193.74).
- Estimated 2,582,200 cancer deaths (1,640,500 males, 941,700 females), with ASMRW of 90.90 per 100,000 (higher in rural areas at 96.27 vs. urban at 87.34).
- Lung cancer is the leading cause of cancer incidence and mortality (1,175,900 new cases, 743,300 deaths, accounting for 22.8% and 28.8% of total cases and deaths, respectively).
- Higher incidence and mortality rates for liver, stomach, and esophageal cancers in rural areas compared to urban areas.
- Higher incidence and mortality rates for colorectal cancer in urban areas compared to rural areas.
- Cervical cancer rates higher in rural areas, while prostate and breast cancer burdens higher in urban areas.
- Regional variations: nasopharyngeal cancer high in Guangxi, Guangdong, Hainan, and Jiangxi; renal cancer prevalent in northern regions; prostate cancer common in economically developed areas.
- Thyroid cancer incidence second highest in Zhejiang, Fujian, and Xinjiang.
- Esophageal and cervical cancer rates significantly lower in Beijing, Tianjin, Shanghai, and Guangdong.